Klinische Studie
Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of active post-resection/ablation therapy in patients with metastatic colorectal cancer(FIRE-9 - PORT / AIO-KRK-0418)Preoperative therapy improves the outcome of patients with resectable colon cancer vs direct surgery followed by adjuvant therapy
Krankheitsentität(en)
Darm (Dickdarm, Mastdarm)
StudientypInterventionsstudiePhase III
StudientypInterventionsstudiePhase III
Wesentliche EinschlusskriterienBiopsy-confirmed adenocarcinoma of the colon
Intent for curative resection 5. Patients with bowel obstruction are only eligible if first stented or defunctioned 6. Tissue is available for pMMR/dMMR testing (centrally and/or locally)
Age ≥ 18 at the time of registration
Statusrekrutierend
Ansprechpartner & KontaktKlinikum Landshut Anstalt des öffentlichen Rechts der Stadt LandshutStudiensekretariat0871 69813338studiensekretariat(at)klinikum-landshut.de